InnoCan Pharma Corporation

CNSX:INNO Stock Report

Market Cap: CA$60.3m

InnoCan Pharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for InnoCan Pharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth53.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We're Hopeful That InnoCan Pharma (CSE:INNO) Will Use Its Cash Wisely

Aug 09
We're Hopeful That InnoCan Pharma (CSE:INNO) Will Use Its Cash Wisely

It's Probably Less Likely That InnoCan Pharma Corporation's (CSE:INNO) CEO Will See A Huge Pay Rise This Year

May 04
It's Probably Less Likely That InnoCan Pharma Corporation's (CSE:INNO) CEO Will See A Huge Pay Rise This Year

Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?

Dec 06
Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?

We Think InnoCan Pharma (CSE:INNO) Can Afford To Drive Business Growth

Aug 15
We Think InnoCan Pharma (CSE:INNO) Can Afford To Drive Business Growth

Companies Like InnoCan Pharma (CSE:INNO) Are In A Position To Invest In Growth

Apr 19
Companies Like InnoCan Pharma (CSE:INNO) Are In A Position To Invest In Growth

Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?

Jul 20
Is InnoCan Pharma (CSE:INNO) In A Good Position To Deliver On Growth Plans?

We Think InnoCan Pharma (CSE:INNO) Needs To Drive Business Growth Carefully

Apr 05
We Think InnoCan Pharma (CSE:INNO) Needs To Drive Business Growth Carefully

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as InnoCan Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

CNSX:INNO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202429-3-2-2N/A
6/30/202424-4-2-2N/A
3/31/202419-5-4-3N/A
12/31/202314-5-4-4N/A
9/30/202310-5-4-4N/A
6/30/20237-3-5-5N/A
3/31/20234-4-6-6N/A
12/31/20223-4-6-6N/A
9/30/20221-3-7-7N/A
6/30/20221-7-7-7N/A
3/31/20220-6-6-6N/A
12/31/20210-10-7-7N/A
9/30/20210-16-5-5N/A
6/30/20210-14-5-5N/A
3/31/20210-14-5-5N/A
12/31/20200-10-4-4N/A
9/30/2020N/A-3-4-4N/A
6/30/2020N/A-5-3-3N/A
3/31/2020N/A-3-3-3N/A
12/31/2019N/A-3-3-3N/A
9/30/2019N/A-6-3-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if INNO's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if INNO's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if INNO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if INNO's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if INNO's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if INNO's Return on Equity is forecast to be high in 3 years time


Discover growth companies